Cargando…
On the probability of cost-effectiveness using data from randomized clinical trials
BACKGROUND: Acceptability curves have been proposed for quantifying the probability that a treatment under investigation in a clinical trial is cost-effective. Various definitions and estimation methods have been proposed. Loosely speaking, all the definitions, Bayesian or otherwise, relate to the p...
Autor principal: | Willan, Andrew R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC58837/ https://www.ncbi.nlm.nih.gov/pubmed/11686854 http://dx.doi.org/10.1186/1471-2288-1-8 |
Ejemplares similares
-
The probability of cost-effectiveness
por: O'Hagan, Anthony, et al.
Publicado: (2002) -
Severity-Adjusted Probability of Being Cost Effective
por: Versteegh, Matthijs M., et al.
Publicado: (2019) -
Methods for analyzing cost effectiveness data from cluster randomized trials
por: Bachmann, Max O, et al.
Publicado: (2007) -
A Comparison of Cost Effectiveness Using Data from Randomized Trials or Actual Clinical Practice: Selective Cox-2 Inhibitors as an Example
por: van Staa, Tjeerd-Pieter, et al.
Publicado: (2009) -
Accounting for treatment by center interaction in sample size determinations and the use of surrogate outcomes in the pessary for the prevention of preterm birth trial: a simulation study
por: Willan, Andrew R.
Publicado: (2016)